|
|
||||||||
From the Department of Neurology, Tel-Aviv Medical Center, and the Sieratzki Chair of Neurology, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Address correspondence and reprint requests to Dr. A.D. Korczyn, Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv 69978, Israel; e-mail: neuro13{at}post.tau.ac.il
The effects of treatment with ropinirole (0.25 to 0.5 mg bid) were examined using an open-label design for 8 weeks in 15 subjects with Gilles de la Tourette syndrome (GdlT). All patients completed the study, and most showed an improvement in their tics during treatment. Low-dose ropinirole may improve the motor features in GdlT, but further controlled studies are necessary.
Received April 2, 2002. Accepted in final form December 30, 2003.
This article has been cited by other articles:
![]() |
D. Gilbert Treatment of Children and Adolescents With Tics and Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 690 - 700. [Abstract] [PDF] |
||||
![]() |
D. L. Gilbert and C. R. Buncher Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette's Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |